Search

everythinglearnresearchcommunity

for

Search:↓

Vitamin D is important for skin health and can help treat and prevent various skin conditions.

Lipid nanoparticles improve drug delivery through the skin, offering stability, controlled release, and better compatibility with skin.

Alopecia areata treatment should be personalized, using topical or systemic therapies based on severity, with promising options like JAK inhibitors needing more research.

Animal models have helped understand hair loss from alopecia areata and find new treatments.

Vitiligo is underreported in medical claims and is linked to certain skin types and autoimmune diseases.

Enzymes that change arginine to citrulline are important for skin barrier and hair formation, and their malfunction can lead to skin conditions and hair disorders.

Tiny particles called extracellular vesicles show promise for treating skin conditions and promoting hair growth.

Canine pemphigus foliaceus involves significant immune activity and shares similarities with human pemphigus.

No single ideal JAK inhibitor for alopecia areata has been determined; JAK3 inhibitors may be promising with fewer side effects.

Hidradenitis Suppurativa has genetic links, with certain gene mutations more common in patients and a third of cases having a family history.

Overexpressing thrombospondin-1 in mice skin prevents UVB-induced skin damage.

Alopecia areata is caused by immune system attacks on hair follicles, often triggered by viral infections.

Chitosan, a natural substance, can be used to create tiny particles that effectively deliver various types of drugs, but more work is needed to improve stability and control of drug release.

In Poland, people search more for certain skin conditions depending on the season, and despite more STD infections, searches for them have decreased, suggesting a need for better sexual education.

Light-based treatment, Photobiomodulation, shows promise for non-invasive skin therapy with few side effects.

The document suggests a possible link between Crohn's disease and Johne's disease and calls for more research.

Double-stranded RNA causes inflammation in hair follicle cells, which may help understand and treat alopecia areata.

Patients with psoriasis and cutaneous-oral lichen planus have higher blood homocysteine levels than healthy people.

JAK inhibitors help with skin conditions but need more research on dosing and safety.

People with hidradenitis suppurativa often have lower vitamin D levels, weaker hip bones, and altered bone metabolism markers.

A deficiency in the TTC7A gene causes immune problems, gut issues, and hair loss.

No strong genetic link to other skin conditions was found, but some genetic factors may make people more likely to get seborrheic dermatitis.

ACTH may be an effective first-line treatment for acute calcium pyrophosphate crystal arthritis.

The document concludes that various hair and scalp disorders in children have specific treatments and proper diagnosis is essential.

New insights into cell communication in psoriasis suggest innovative drug treatments.

Oxidative stress is important in causing alopecia areata.

Topical calcineurin inhibitors, especially 0.1% tacrolimus ointment, are effective and well-tolerated for treating cutaneous lupus erythematosus but require more research for standard treatment guidelines.

CD201+ fascia progenitors are essential for wound healing and could be targeted for treating skin conditions.

Melanocyte-associated antigens may play a key role in alopecia areata and could be targets for new treatments.

People with alopecia areata may have a higher risk of blood clots.